The effect of hydroalcoholic extract of Ferula foetida stems on blood pressure and oxidative stress in dexamethasone-induced hypertensive rats

Research in Pharmaceutical Sciences

Volumn 10, Issue 4, 2015, Pages 326-334

  Safaeian, Leila ^a   Ghannadi, Alireza ^a   Javanmard, Shaghayegh Haghjoo ^b   Vahidian, Mohammad Hadi ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidant activity; Dexamethasone; Ferula foetida; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; CAPTOPRIL; DEXAMETHASONE; FERULA FOETIDA EXTRACT; GLUCOCORTICOID; HYDROGEN PEROXIDE; HYDROPEROXIDE; PHENOL DERIVATIVE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG DETERMINATION; HYPERTENSION; MALE; NONHUMAN; ORGAN WEIGHT; OXIDATIVE STRESS; PLANT STEM; PREVENTION STUDY; RAT; SYSTOLIC BLOOD PRESSURE; THIN LAYER CHROMATOGRAPHY; THYMUS; THYMUS WEIGHT; ULTRAVIOLET SPECTROPHOTOMETRY; WEIGHT GAIN;

EID: 84941549561     PISSN: 17355362     EISSN: 17359414     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care, the Framingham Heart Study. Circulation. 2008;117:743-753.
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-223.
3. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet. 2003;362:1527-1535.
4. Fatehi M, Saleh TM, Fatehi-Hassanabad Z, Farokhfal K, Jafarzadeh M, Davodi S. A pharmacological study on Berberis vulgaris fruit extract. J Ethnopharmacol. 2005;102:46-52.
5. Tabassum N, Ahmad F. Role of natural herbs in the treatment of hypertension. Pharmacogn Rev. 2011;5:30-40.
6. Sahebkar A, Iranshahi M. Biological activities of essential oils from the genus Ferula (Apiaceae). Asian Biomed. 2010;4:835-847.
7. Iranshahy M, Iranshahi M. Traditional uses, phytochemistry and pharmacology of asafoetida (Ferula assa-foetida oleo-gum-resin)-A review. J Ethnopharmacol. 2011;134:1-10.
8. Ghannadi A, Fattahian K, Shokoohinia Y, Behbahani M, Shahnoush A. Anti-viral evaluation of sesquiterpenecoumarins from Ferula assa-foetida against HSV-1. Iran J Pharm Res. 2014;13:523-530.
9. Iranshahi M, Sahebkar A, Hosseini ST, Takasaki M, Konoshima T, Tokuda H. Cancer chemopreventive activity of diversion from Ferula diversivittata in vitro and in vivo. Phytomedicine. 2010;17:269-273.
10. Nabavi SM, Ebrahimzadeh MA, Nabavi SF, Eslami B, Dehpour AA. Antioxidant and antihaemolytic activity of Ferula foetida Regel (Umbelliferae). Eur Rev Med Pharmacol Sci. 2011;15:157-164.
11. Kareparamban JA, Nikam PH, Jadhav AAP, Kadam VJ. Ferula foetida "Hing": A Review. Res J Pharm Biol Chem Sci. 2012;3:775-786.
12. Javaid R, Aslam M, Javaid R, Nizami Q, Javed K, Azhar M. Extract of Ferula foetida Regel reverses gentamicin-induced nephrotoxicity in rats. EXCLI J. 2012;11:760-766.
13. Ghannadi A, Sajjadi SE, Beigi Hassan A. Composition of the essential oil of Ferula ovina Boiss. from Iran. Daru J Pharm Sci. 2012;10: 165-167.
14. Srinivasan M, Sudheer AR, Menon VP. Ferulic Acid: Therapeutic potential through its antioxidant property. J Clin Biochem Nutr. 2007;40:92-100.
15. Minaiyan M, Ghannadi A, Etemad M, Mahzuni P. A study of the effects of Cydonia oblonga Miller (Quince) on TNBS-induced ulcerative colitis in rats. Res Pharm Sci. 2012;7:103-110.
16. Mabinya LV, Mafunga T, Brand JM. Determination of ferulic acid and related compounds by thin layer chromatography. Afr J Biotechnol. 2006;5:1271-1273.
17. Zhang Y, Wu JH, Vickers JJ, Ong SL, Temple SE, Mori TA, et al. The role of 20-hydroxyeicosatetraenoic acid in adrenocorticotropic hormone and dexamethasone-induced hypertension. J Hypertens. 2009;27:1609-1616.
18. Ong SL, Vickers JJ, Zhang Y, McKenzie KU, Walsh CE, Whitworth JA. Role of xanthine oxidase in dexamethasone-induced hypertension in rats. Clin Exp Pharmacol Physiol. 2007;34:517-519.
19. Wolff SP. Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Methods Enzymol. 1994;233: 182-189.
20. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem. 1996;239:70-76.
21. Ong SLH, Zhang Y, Whitworth JA. Mechanisms of dexamethasone-induced hypertension. Curr Hypertens Rev. 2009;5:61-74.
22. Zhang Y, Croft KD, Mori TA, Schyvens CG, McKenzie KU, Whitworth JA. The antioxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat. Am J Hypertens. 2004;17:260-265.
23. Safaeian L, Zabolian H. Antioxidant effects of bovine lactoferrin on dexamethasone-induced hypertension in rat. ISRN Pharmacol. 2014;2014: ID 943523.
24. Fatehi M, Farifteh F, Fatehi-Hassanabad Z. Antispasmodic and hypotensive effect of Ferula assafoetida gum extract. J Ethnopharmacol. 2004;9:321-324.
25. Kassis E, Folder S, Khalil Kh, Hadieh B, Nahhas F, Saad B, et al. Efficacy and safety assessments of Ferula assa-foetida L. traditionally used in Greco-Arab herbal medicine for enhancing male fertility, libido and erectile function. Open Complemt Med J. 2009;1:102-109.
26. Suzuki A, Yamamoto M, Jokura H, Fujii A, Tokimitsu I, Hase T, et al. Ferulic acid restores endothelium-dependent vasodilation in aortas of spontaneously hypertensive rats. Am J Hypertens. 2007;20:508-513.
27. Alam MA, Sernia C, Brown L. Ferulic acid improves cardiovascular and kidney structure and function in hypertensive rats. J Cardiovasc Pharmacol. 2013;61:240-249.
28. Feng W, Min LI, Lianchun Y, Jingyuan W, Min L, Fei LA. New kind of non-peptide endothelin antagonist caffeic acid, ferulic acid. Yao xue xue bao. 1999;34:898-901.
29. Perez-Vizcaino F, Duarte J. Flavonoids and cardiovascular disease. Mol Asp Med. 2010;31: 478-494.
30. Sethi A, Sharma RA. Antioxidant activity with total phenolic constituents from Aerva tomentosa Forks. Int J Pharm Biol Sci. 2011;2:596-603.
31. Chandra S, Khan S, Avula B, Lata H, Yang MH, ElSohly MA, et al. Assessment of total phenolic and flavonoid content, antioxidant properties, and yield of aeroponically and conventionally grown leafy vegetables and fruit crops: A comparative study. Evid Based Complement Alterant Med. 2014;2014:253875.
32. Khopde SM, Priyadarsini KI, Guha SN, Mukherjee T. Hydroxyl radical induced oxidation of 3-methoxy-4-hydroxy cinnamic acid (ferulic acid). Res Chem Intermediat. 2001;27:519-527.
33. Bartosz M, Kedziora J, Bartosz G. Antioxidant and prooxidant properties of captopril and enalapril. Free Radic Biol Med. 1997;23:729-735.
34. Benzie IFF, Tomlinson B. Antioxidant power of angiotensin-converting enzyme inhibitors in vitro. Br J Clin Pharmacol. 1998;45:168-169.
35. Michel C, Cabanac M. Effects of dexamethasone on the body weight set point of rats. Physiol Behav. 1999;68:145-150.
36. Lerario DDG, Ferreira SRG, Miranda EL, Chacra AR. Influence of dexamethasone and weight loss on the regulation of serum leptin levels in obese individuals. Braz J Med Biol Res. 2001;34:479-487.
37. Chmielewski V, Drupt F, Morfin R. Dexamethasone-induced apoptosis of mouse thymocytes: Prevention by native 7α-hydroxysteroids. Immunol Cell Biol. 2000;78: 238-246.
38. Kong F, Chen CH, Cooper MD. Reversible disruption of thymic function by steroid treatment. J Immunol. 2002;168:6500-6505.